IL4 and infectious otitis media: The anti-inflammatory factors IL-10 and IL-4 were decreased in the AOM/DSS treatment group compared with the NOR group, and the group administered orally with TFB and NFB demonstrated recovery similar to the NOR group (p < 0.05).